Roughly half of all people who develop Alzheimer's disease do not carry even a single copy of APOE4, illustrating that the gene is a risk factor but not destiny.
Snapshot · The Peter Attia Drive
Roughly half of all people who develop Alzheimer's disease do not carry even a single copy of APOE4, illustrating that the gene is a risk factor but not destiny.
Where this was said
At 28:57 · chapter starts 28:45
Neurodegenerative disease is the most emotionally complex category, and Peter treats it accordingly. APOE4 is the strongest common genetic risk factor for Alzheimer's disease: two copies can raise risk up to 15 times higher than in non-carriers [1] — Peter Attia "APOE4 homozygous: up to 15x Alzheimer's risk: Individuals with two copies of APOE4 may face an Alzheimer's disease risk up to 15 times high…" 28:44 . But it is not destiny — roughly half of Alzheimer's patients do not carry even a single APOE4 allele. Peter argues that knowing APOE status can still be useful, for several reasons. It may help personalize management of modifiable risk factors like lipids and metabolic health. Emerging therapies like Opicetrapib are being studied specifically in APOE4 carriers, suggesting a future where genetic status informs therapeutic choice. And for some patients, especially those with a family history of dementia, knowledge of APOE status is less about medicine and more about financial and care planning — conversations that are far easier to have years before a crisis than during one. Beyond APOE, only about 10% of Parkinson's and ALS cases are attributable to known genetic mutations, making broad screening in these conditions rarely appropriate. Testing here is almost always a deeply personal decision driven by a specific family circumstance, and the psychological dimension — whether the information is likely to be useful for that particular person — matters more here than anywhere else.
Only about 10% of Parkinson's disease and ALS cases are due to known genetic mutations, making broad genetic screening rarely appropriate for these conditions.
Up to 40% of people carry MTHFR variants — which is exactly why they can't be driving serious disease. Natural selection weeds out harmful variants. The functional medicine industry exploits their prevalence to sell supplement protocols to nearly everyone, with virtually no clinical evidence to support them.
Mental health challenges are nearly universal — BetterHelp's own research found the majority of Americans experiencing symptoms right now.
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
Men's overdose death rate fell 27% in a single year, outpacing the 23% drop for women.
The steepest decline in overdose deaths was among 15–24-year-olds, whose rate fell 37%.
Fei-Fei Li observed that on a given hospital shift, nurses walk miles just to fetch medicine and supplies, illustrating a clear use case for assistive robotics in healthcare.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.